Onyx Pharmaceuticals, Inc. 소개
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
본사Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
설립2013
상태운영 중
특허특허 60건
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
법적 정보
| 법인명 | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853GLEIF에서 보기 ↗ |
| 등기 주소 | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| 상태 | 운영 중 |
출처: GLEIF · 2026년 10월 16일 업데이트
연락처 및 링크
위치
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
귀하의 회사인가요?
이 페이지를 무료로 신청하여 로고, 제품, 사진, 채용 공고를 추가하고 리뷰에 답변하세요.
이 페이지 신청